A. Pękala, D. Aebisher, P. Pardak, and R. Filip, “Efficacy and safety of biosimilar IFX (CT-P13) and adalimumab in patients with active fistulizing perianal Crohn’s disease naďve to anti-TNF therapy: preliminary results from the POLIBD study”, Eur J Clin Exp Med, vol. 17, no. 1, pp. 12–15, Mar. 2019.